Anthony John DeRosa - Mar 1, 2022 Form 4/A - Amendment Insider Report for Evolv Technologies Holdings, Inc. (EVLV)

Role
Chief Revenue Officer
Signature
/s/ Eric Pyenson, Attorney-in-fact for Anthony John DeRosa
Stock symbol
EVLV
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
9/15/2022, 08:30 PM
Date Of Original Report
Mar 3, 2022
Previous filing
Sep 28, 2021
Next filing
Jun 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLV Stock Option (Right to Buy) Award $0 +269K $0.00 269K Mar 1, 2022 Class A Common Stock 269K $3.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to 25% of the underlying shares on March 1, 2023 and in 12 equal quarterly installments thereafter.

Remarks:

This amendment is being filed to amend the original Form 4 filed on March 3, 2022 (the "Original Form 4") solely to correct the exercise price in Column 2 of Table II which was inadvertently incorrectly reported in the Original Form 4. All other information in the Original Form 4 remains unchanged.